Compare GSK Pharma with FDC LTD. - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

GSK PHARMA vs FDC LTD. - Comparison Results

GSK PHARMA     Change

GSK Pharma is one of the leading MNC pharma companies in the Indian market. It is a 50.7% subsidiary of GlaxoSmithKline Plc, one of the world's largest pharma companies. GSK Pharma's product portfolio boasts of some of the leading brands like Augment... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    GSK PHARMA FDC LTD. GSK PHARMA/
FDC LTD.
 
P/E (TTM) x 55.8 16.2 343.3% View Chart
P/BV x 11.7 2.2 533.6% View Chart
Dividend Yield % 1.3 0.0 -  

Financials

 GSK PHARMA   FDC LTD.
EQUITY SHARE DATA
    GSK PHARMA
Mar-19
FDC LTD.
Mar-18
GSK PHARMA/
FDC LTD.
5-Yr Chart
Click to enlarge
High Rs3,595319 1,127.0%   
Low Rs1,253164 764.0%   
Sales per share (Unadj.) Rs184.761.6 299.6%  
Earnings per share (Unadj.) Rs26.39.9 264.3%  
Cash flow per share (Unadj.) Rs29.212.0 243.7%  
Dividends per share (Unadj.) Rs20.000-  
Dividend yield (eoy) %0.80-  
Book value per share (Unadj.) Rs126.373.2 172.6%  
Shares outstanding (eoy) m169.40174.40 97.1%   
Bonus/Rights/Conversions -BB-  
Price / Sales ratio x13.13.9 335.1%   
Avg P/E ratio x92.224.3 379.8%  
P/CF ratio (eoy) x83.120.2 411.8%  
Price / Book Value ratio x19.23.3 581.4%  
Dividend payout %76.10-   
Avg Mkt Cap Rs m410,62642,118 975.0%   
No. of employees `0005.05.5 89.7%   
Total wages/salary Rs m5,3722,167 247.9%   
Avg. sales/employee Rs Th6,306.71,943.7 324.5%   
Avg. wages/employee Rs Th1,083.1391.7 276.5%   
Avg. net profit/employee Rs Th898.0313.7 286.3%   
INCOME DATA
Net Sales Rs m31,28110,751 291.0%  
Other income Rs m1,023510 200.8%   
Total revenues Rs m32,30411,260 286.9%   
Gross profit Rs m6,0092,267 265.1%  
Depreciation Rs m486351 138.3%   
Interest Rs m614 42.9%   
Profit before tax Rs m6,5402,411 271.2%   
Minority Interest Rs m0-5 0.0%   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m2870-   
Tax Rs m2,373671 353.5%   
Profit after tax Rs m4,4541,735 256.7%  
Gross profit margin %19.221.1 91.1%  
Effective tax rate %36.327.8 130.3%   
Net profit margin %14.216.1 88.2%  
BALANCE SHEET DATA
Current assets Rs m20,0617,213 278.1%   
Current liabilities Rs m14,5432,104 691.3%   
Net working cap to sales %17.647.5 37.1%  
Current ratio x1.43.4 40.2%  
Inventory Days Days5754 104.2%  
Debtors Days Days1428 50.7%  
Net fixed assets Rs m14,3436,865 208.9%   
Share capital Rs m1,694175 966.9%   
"Free" reserves Rs m19,70412,586 156.6%   
Net worth Rs m21,39812,761 167.7%   
Long term debt Rs m26 33.3%   
Total assets Rs m39,11315,041 260.0%  
Interest coverage x1,091.0173.2 629.8%   
Debt to equity ratio x00 19.9%  
Sales to assets ratio x0.80.7 111.9%   
Return on assets %11.411.6 98.1%  
Return on equity %20.813.6 153.1%  
Return on capital %31.919.0 168.4%  
Exports to sales %012.3 0.0%   
Imports to sales %00-   
Exports (fob) Rs mNA1,327 0.0%   
Imports (cif) Rs mNANA-   
Fx inflow Rs m5341,889 28.3%   
Fx outflow Rs m7,0910-   
Net fx Rs m-6,5571,889 -347.1%   
CASH FLOW
From Operations Rs m3,9941,498 266.5%  
From Investments Rs m-1,433201 -712.8%  
From Financial Activity Rs m-3,584-1,694 211.5%  
Net Cashflow Rs m-1,02310 -9,934.0%  

Share Holding

Indian Promoters % 0.0 68.9 -  
Foreign collaborators % 50.7 0.0 -  
Indian inst/Mut Fund % 10.2 4.7 217.0%  
FIIs % 23.8 7.5 317.3%  
ADR/GDR % 0.0 0.0 -  
Free float % 15.4 19.0 81.1%  
Shareholders   102,036 23,730 430.0%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare GSK PHARMA With:   ELDER PHARMA  TTK HEALTHCARE  SHASUN PHARMA  STRIDES PHARMA SCIENCE  J.B.CHEMICALS  

Compare GSK PHARMA With:   MYLAN (US)  ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

Sensex Ends 334 Points Lower; IT and Telecom Stocks Witness Huge Selling(Closing)

India share markets witnessed selling pressure during closing hours and ended their day deep in the red. At the closing bell, the BSE Sensex stood lower by 334 points (down 0.9%).

Related Views on News

FDC LTD. Announces Quarterly Results (1QFY20); Net Profit Up 2.4% (Quarterly Result Update)

Aug 6, 2019 | Updated on Aug 6, 2019

For the quarter ended June 2019, FDC LTD. has posted a net profit of Rs 523 m (up 2.4% YoY). Sales on the other hand came in at Rs 3 bn (up 17.9% YoY). Read on for a complete analysis of FDC LTD.'s quarterly results.

GSK PHARMA Announces Quarterly Results (1QFY20); Net Profit Up 28.1% (Quarterly Result Update)

Jul 24, 2019 | Updated on Jul 24, 2019

For the quarter ended June 2019, GSK PHARMA has posted a net profit of Rs 1 bn (up 28.1% YoY). Sales on the other hand came in at Rs 8 bn (up 7.1% YoY). Read on for a complete analysis of GSK PHARMA's quarterly results.

GSK PHARMA 2018-19 Annual Report Analysis (Annual Result Update)

Jun 24, 2019 | Updated on Jun 24, 2019

Here's an analysis of the annual report of GSK PHARMA for 2018-19. It includes a full income statement, balance sheet and cash flow analysis of GSK PHARMA. Also includes updates on the valuation of GSK PHARMA.

FDC LTD. Announces Quarterly Results (4QFY19); Net Profit Up 6.8% (Quarterly Result Update)

May 30, 2019 | Updated on May 30, 2019

For the quarter ended March 2019, FDC LTD. has posted a net profit of Rs 337 m (up 6.8% YoY). Sales on the other hand came in at Rs 3 bn (down 0.6% YoY). Read on for a complete analysis of FDC LTD.'s quarterly results.

GSK PHARMA Announces Quarterly Results (4QFY19); Net Profit Up 16.6% (Quarterly Result Update)

May 21, 2019 | Updated on May 21, 2019

For the quarter ended March 2019, GSK PHARMA has posted a net profit of Rs 1 bn (up 16.6% YoY). Sales on the other hand came in at Rs 8 bn (up 0.3% YoY). Read on for a complete analysis of GSK PHARMA's quarterly results.

More Views on News

Most Popular

My 3 Best Small-cap Stocks to Get Rich in this Market Rebound(Profit Hunter)

Oct 14, 2019

This is once in a decade opportunity to make a killing from smallcap rebound.

Buy these 3 Stocks for Rebound Riches

Oct 18, 2019

Equitymaster's smallcap guru and editor of Hidden Treasure, Richa Agarwal, talks to us about the rebound in the stock market, and the best stocks to profit from it. Listen in...

Two Stocks to Buy in the Great Indian Festival(Profit Hunter)

Oct 11, 2019

Discounts are not just limited to E-tailers. You can buy stocks at 50% off too. Here are two stocks to buy now.

The One Stock I Like in this Market(The 5 Minute Wrapup)

Oct 10, 2019

There are rare periods in markets when you get good quality stocks at attractive valuations. Is this one such period?

5 Smart Money Stocks to Profit from the Market Rebound(The 5 Minute Wrapup)

Oct 11, 2019

Now is the time to put money in these 5 stocks to take advantage of the recovery in the economy and the markets.

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2020
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

GSK PHARMA SHARE PRICE


Oct 22, 2019 (Close)

TRACK GSK PHARMA

  • Track your investment in GSK PHARMA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

GSK PHARMA - ALEMBIC LTD COMPARISON

COMPARE GSK PHARMA WITH

MARKET STATS